SERA Prognostics, Inc.

Medical Devices • Healthcare • Salt Lake City, UT, United States • SERA (NGM)

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS - PR Newswire

PR Newswire • Nov 13

With 40% ownership, Sera Prognostics, Inc. (NASDAQ:SERA) has piqued the interest of institutional investors - Yahoo Finance

Yahoo Finance • Dec 28

Jefferies initiates Sera Prognostics stock with Buy rating on preterm birth test - Investing.com

Investing.com • Dec 15

Sera Prognostics: Few Takers For A Great Product Spells Angst (NASDAQ:SERA) - Seeking Alpha

Seeking Alpha • Sep 22

Sera Prognostics (SERA) Price Target Increased by 81.82% to 5.10 - Nasdaq

Nasdaq • Dec 20

Other Medical Devices Companies

View All →

Abbott Laboratories

$218.91B market cap

Boston Scientific Corp.

Edwards Lifesciences Corp.

$51.04B market cap

Dexcom Inc.

$26.50B market cap

Frequently Asked Questions

Has SERA PROGNOSTICS, INC. had layoffs?

No layoff events have been recorded for SERA PROGNOSTICS, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does SERA PROGNOSTICS, INC. have?

SERA PROGNOSTICS, INC. has approximately 63 employees.

What industry is SERA PROGNOSTICS, INC. in?

SERA PROGNOSTICS, INC. operates in the Medical Devices industry, within the Healthcare sector.

Is SERA PROGNOSTICS, INC. a publicly traded company?

Yes, SERA PROGNOSTICS, INC. is publicly traded under the ticker symbol SERA on the NGM. The company has a market capitalization of approximately $0.13 billion.

Where is SERA PROGNOSTICS, INC. headquartered?

SERA PROGNOSTICS, INC. is headquartered in Salt Lake City, UT, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.